The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Author Title [ Type(Asc)] Year
Filters: Author is Akriviadis, Evangelos  [Clear All Filters]
Journal Article
Sinakos, E., Hytiroglou P., Chourmouzi D., & Akriviadis E. (2015).  Focal nodular hyperplasia in an individual with Abernethy malformation type 1b.. Dig Liver Dis. 47(12), 1089.
Cholongitas, Ε., Goulis I., Theocharidou E., Antoniadis N., Fouzas I., Giakoustidis D., et al. (2014).  Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.. Hepatol Int. 8(1), 137-45.
Louvet, A., Thursz M. R., Kim D. Joon, Labreuche J., Atkinson S. R., Sidhu S. Singh, et al. (2018).  Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.. Gastroenterology. 155(2), 458-468.e8.
Cholongitas, E., Ioannidou M., Goulis I., Chalevas P., Ntogramatzi F., Athanasiadou Z., et al. (2017).  Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis.. J Gastroenterol Hepatol. 32(1), 191-198.
Fotiadu, A., Gagalis A., Akriviadis E., Kotoula V., Sinakos E., Karkavelas G., et al. (2010).  Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease.. Pathol Int. 60(2), 87-92.
Kiapidou, S., Liava C., Kalogirou M., Akriviadis E., & Sinakos E. (2020).  Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?. Ann Hepatol. 19(2), 134-144.
Papatheodoridis, G., Goulis J., Manolakopoulos S., Margariti A., Exarchos X., Kokkonis G., et al. (2014).  Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.. J Hepatol. 60(1), 62-8.
Cholongitas, E., Karatapanis S., Nakouti T., Birtsou C., Skorda L., Kouvelis I., et al. (2012).  Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?. Liver Int. 32(1), 172-3.
Manolakopoulos, S., Kranidioti H., Goulis J., Vlachogiannakos J., Elefsiniotis J., Kouroumalis E. A., et al. (2015).  Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.. Ann Gastroenterol. 28(4), 481-6.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Authors' reply.. Ann Gastroenterol. 28(4), 507.
Cholongitas, E., Goulis J., Arsos G., Birtsou C., Nakouti T., Papadopoulou S., et al. (2013).  Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis.. Clin Gastroenterol Hepatol. 11(7), 862-7.
Papachrysos, N., Hytiroglou P., Papalavrentios L., Sinakos E., Kouvelis I., & Akriviadis E. (2015).  Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.. Ann Gastroenterol. 28(3), 374-378.
Paschos, P., Ioakim K., Malandris K., Koukoufiki A., Nayfeh T., Akriviadis E., et al. (2021).  Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.. Anaerobe. 71, 102441.
Papalavrentios, L., Sinakos E., Chourmouzi D., Hytiroglou P., Drevelegas K., Drevelegas A., et al. (2013).  3 Tesla diffusion-weighted MRI for assessing liver fibrosis in nonalcoholic fatty liver disease.. Hepatology. 58(1), 449-50.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.